PFIZER2020-07-012020-09-30in-bse-fin:OneOperatingExpenses01Member PFIZER2020-07-012020-09-30in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PFIZER 2020-04-01 2021-03-31 2020-10-22 INR Crores Half yearly true Cash Flow Indirect Single segment Pharmaceuticals 2020-07-01 2020-09-30 Unaudited Standalone 5954100000.00 121500000.00 6075600000.00 830300000.00 1001200000.00 286600000.00 862100000.00 47100000.00 277300000.00 940700000.00 4245300000.00 1830300000.00 0.00 1830300000.00 566100000.00 -49500000.00 516600000.00 0.00 1313700000.00 0.00 0.00 0.00 0.00 1313700000.00 -21900000.00 1291800000.00 0.00 0.00 457500000.00 10 28.71 28.71 0.00 0.00 28.71 28.71 1. The above results were reviewed and recommended by the Audit Committee, for approval by the Board, at its Meeting held on 02 November 2020 and were approved and taken on record at the Meeting of the Board of Directors of the Company held on that date. n n2. The financial results of the Company have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As amended) and SEBI circular dated July 5, 2016. n n3. The financial results for quarter and half year ended 30 September 2020 have been subjected to limited review by the statutory auditors of the Company. The limited review report does not contain any modifications. The limited review report will be filed with the Stock Exchanges and will also be available on the Company’s website - www.pfizerindia.com n n4. The Company has only one segment which is ‘Pharmaceuticals’. Therefore, disclosure relating to segments is not applicable and accordingly not made. n n5. During the quarter ended 30 September 2019, the Company elected to exercise the option permitted under section 115BAA of the Income Tax Act, 1961 as introduced by the Taxation Laws (Amendment) Ordinance, 2019. Accordingly, the Company had recognized Provision for Income Tax for the six months ended September 30, 2019 and re-measured its Deferred tax assets basis the rate prescribed in the said section. The impact of this change related to the quarter ended 30 June 2019 was recognized in the quarter ended 30 September 2019. n n6. Other non-current assets include Rs. 162.95 Crores of Income tax receivable (net). Single segment 2020-04-01 2020-09-30 Unaudited Standalone 11103000000.00 293500000.00 11396500000.00 1563300000.00 2220800000.00 109900000.00 1721100000.00 77200000.00 548700000.00 1591800000.00 7832800000.00 3563700000.00 0.00 3563700000.00 1066500000.00 -61000000.00 1005500000.00 0.00 2558200000.00 0.00 0.00 0.00 0.00 2558200000.00 -43900000.00 2514300000.00 0.00 0.00 457500000.00 10 55.92 55.92 0.00 0.00 55.92 55.92 Other Expenses 940700000.00 Other Expenses 1591800000.00 3563700000.00 3563700000.00 3563700000.00 3563700000.00 3563700000.00